Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
about
Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells.Streptococcus pneumoniae.Activation of the alternative pathway of complement by mycobacteria and cord factor.Alterations in serum opsonic activity and complement levels in pneumococcal disease.Activation of the alternative complement pathway by L-phase variants of gram-positive bacteriaActivation of complement by cell surface components of Staphylococcus aureus.Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosumGram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes.Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components.Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.Release of lipoteichoic acid from Streptococcus sanguis: stimulation of release during penicillin treatment.Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsuleProtection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several typesFactors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid.Differential complement resistance mediates virulence of Haemophilus influenzae type bRole of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae.Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.Opsonized streptococcal cell walls cross-link human leukocytes and erythrocytes by complement receptorsAntibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.Activation of the alternative complement pathway by pneumococcal lipoteichoic acidActivation of human complement by the pneumococcal toxin pneumolysinRelationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.Interaction of pneumococcal antigens with complement in rats.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Interaction of purified lipoteichoic acid with the classical complement pathway.Cercarial glycocalyx of Schistosoma mansoni activates human complement.Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.Activation of the alternative complement pathway by a streptococcal lipoteichoic acid.Immunosuppression of anti-sheep erythrocyte responses by glycerol teichoic acid immune complexes.Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways.Bacterial infections and cancer
P2860
Q33596128-E2F99FBF-10C8-455C-B392-57637BB83857Q33602800-B9A4882A-96E2-4327-9CB7-09FC93C1720EQ33734675-85FF3499-0607-4590-B4D3-E173C17C6313Q33904845-383D0A34-695C-4C04-BD75-0B0580162204Q33907928-536E782C-3BAF-4069-8CAF-A72F788B66FFQ34080073-D328562F-AB7A-408F-ABE6-3CF8DD696365Q34444984-24B2E7B4-8784-44B8-894D-D3430B8BC264Q34460951-68426974-107A-4ED9-966B-E9F4F92C0DB7Q34528810-3E220447-4C2D-4E25-937D-1427338708C6Q35110548-8B2ED9BC-D0F7-49CA-B293-026CCD249206Q35605613-64D99D43-D632-4FE3-BE64-65D3C28C99DAQ35689073-44603C7B-72FC-4ADB-ACFC-2BBE1CD0BCD3Q35923195-BC8437F9-BC4E-40CD-9DD4-C29BBEC3B9A6Q36338515-A441B925-D3CA-4B69-85C4-6C54E5887305Q36342702-323E272E-0E18-4C23-81C8-016EA39FA740Q36345169-13495116-7584-4B60-AD49-70D9256FBE3AQ36422669-F33BF078-4768-4B61-AA9E-B3F6366457ECQ36433753-4315B138-2AD1-412C-ADE9-87ACD60A2863Q36947758-46F0C047-AB46-4D54-A76B-ECEF9F9E59D6Q37027498-1980FCA9-D7E1-495F-AEBC-BE3A7D62E407Q37032554-3D9055E7-8502-4DBC-B093-AE2BF97B4781Q37033022-ADAD2E83-4C9A-4309-9352-8288D046E92FQ37074903-185B8F02-4284-4681-B9CF-B66B9C359C91Q37097815-9D62F243-A0FB-41EE-ABAD-37642436C1DFQ37200932-FAD4ED74-ED68-406E-A0D9-071DB8FD6BB9Q37596659-E35CD3B6-9145-46D0-A4BD-60B872C43ACAQ39257252-B0AB9B4B-510F-4247-BA69-19436D222F2CQ40056277-A8F24156-4FD8-47E9-889E-36E3D9A41C1BQ40164838-BECF7C62-359E-4347-A1AC-ABD1B82F0385Q40166109-3EA98997-333F-418E-A3F9-B403C1BE4911Q40830914-09E2759B-5B9D-4221-803A-D10DA48F0DEFQ40911951-ED8BAFFC-41FD-483D-A3E0-BA5580C152C4Q41189404-929B5680-4167-47B5-9664-136639384663Q42727806-9B4A5B0B-DE44-4654-BA22-66F8802E53A9Q57802480-3FC2667D-2E9F-4766-B180-D82E73FE2D05
P2860
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@en
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@nl
type
label
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@en
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@nl
prefLabel
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@en
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@nl
P1476
Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
@en
P2093
Winkelstein JA
P304
P407
P577
1978-01-01T00:00:00Z